Infliximab treatment of patients with birdshot retinochoroidopathy.

[1]  L. Carmona,et al.  Systematic review on the effectiveness of immunosuppressants and biological therapies in the treatment of autoimmune posterior uveitis. , 2011, Seminars in arthritis and rheumatism.

[2]  C. Edwards,et al.  Anti-TNF-induced lupus. , 2009, Rheumatology.

[3]  Justine R. Smith,et al.  Infliximab therapy for refractory uveitis: 2-year results of a prospective trial. , 2009, Archives of ophthalmology.

[4]  N. Hajjaj-Hassouni,et al.  Guillain–Barre in a patient with ankylosing spondylitis secondary to ulcerative colitis on infliximab therapy , 2009, Clinical Rheumatology.

[5]  B. Zimmermann,et al.  Drug-Induced Lupus due to Anti-Tumor Necrosis Factor α Agents , 2008 .

[6]  L. Sobrin,et al.  Daclizumab for treatment of birdshot chorioretinopathy. , 2008, Archives of ophthalmology.

[7]  S. Silburn,et al.  Guillain–Barré syndrome in a patient receiving anti-tumour necrosis factor α for rheumatoid arthritis: a case report and discussion of literature , 2007, Annals of the rheumatic diseases.

[8]  B. Zimmermann,et al.  Drug-induced lupus due to anti-tumor necrosis factor alpha agents. , 2008, Seminars in arthritis and rheumatism.

[9]  L. Cimino,et al.  Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study. , 2007, Rheumatology.

[10]  M. Khamashta,et al.  Autoimmune Diseases Induced by TNF-Targeted Therapies: Analysis of 233 Cases , 2007, Medicine.

[11]  L. Sobrin,et al.  Infliximab therapy for the treatment of refractory ocular inflammatory disease. , 2007, Archives of ophthalmology.

[12]  P. Sfikakis,et al.  TUMOR NECROSIS FACTOR ANTAGONISTS: Preliminary Evidence for an Emerging Approach in the Treatment of Ocular Inflammation , 2007, Retina.

[13]  A. Dick,et al.  Tumor Necrosis Factor Alpha-Targeted Therapies in Uveitis , 2007 .

[14]  T. Demir,et al.  The effect of infliximab, cyclosporine A and recombinant IL-10 on vitreous cytokine levels in experimental autoimmune uveitis. , 2006, Indian journal of ophthalmology.

[15]  E. Papadopoulos,et al.  Guillain-Barré and Miller Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy. , 2006, Arthritis and rheumatism.

[16]  J. Folch,et al.  Retrospective case review of pediatric patients with uveitis treated with infliximab , 2006 .

[17]  A. Rothova,et al.  Research criteria for the diagnosis of birdshot chorioretinopathy: results of an international consensus conference. , 2006, American journal of ophthalmology.

[18]  P. Manners,et al.  Infliximab for juvenile idiopathic arthritis‐associated uveitis , 2005, Clinical & experimental ophthalmology.

[19]  Douglas A Jabs,et al.  Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. , 2005, American journal of ophthalmology.

[20]  J. García-Sánchez,et al.  Long-term treatment of refractory posterior uveitis with anti-TNFα (infliximab) , 2005, Eye.

[21]  J. Kempen,et al.  Birdshot retinochoroidopathy: ocular complications and visual impairment. , 2005, American journal of ophthalmology.

[22]  Justine R. Smith,et al.  A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes. , 2005, Archives of ophthalmology.

[23]  S. Kiss,et al.  Long-term follow-up of patients with birdshot retinochoroidopathy treated with corticosteroid-sparing systemic immunomodulatory therapy. , 2005, Ophthalmology.

[24]  R. Kuijpers,et al.  Anti-TNF-α therapy for sight threatening uveitis , 2005, British Journal of Ophthalmology.

[25]  X. Mariette,et al.  Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey , 2005, Arthritis research & therapy.

[26]  Justine R. Smith,et al.  Long-Term Follow-Up of Patients with Birdshot Retinochoroidopathy Treated with Systemic Immunosuppression , 2005, Ocular immunology and inflammation.

[27]  F. Yu,et al.  Birdshot chorioretinopathy. , 2005, Survey of ophthalmology.

[28]  J. Martinez-de-la-Casa,et al.  Long-term treatment of refractory posterior uveitis with anti-TNFalpha (infliximab). , 2005, Eye.

[29]  R. Baughman,et al.  Infliximab in chronic ocular inflammation. , 2005, International journal of clinical pharmacology and therapeutics.

[30]  W. Benson.  BIRDSHOT CHORIORETINOPATHY: LONG-TERM MANIFESTATIONS AND VISUAL PROGNOSIS , 2004 .

[31]  J. Loewenstein,et al.  Electroretinograms as an indicator of disease activity in birdshot retinochoroidopathy , 2002, Graefe's Archive for Clinical and Experimental Ophthalmology.

[32]  J. Folk,et al.  Birdshot retinochoroiditis: long term follow-up of a chronically progressive disease. , 2002, American journal of ophthalmology.

[33]  S. Lightman,et al.  Immunopathology of the noninfectious posterior and intermediate uveitides. , 2001, Survey of ophthalmology.

[34]  P. Theodossiadis,et al.  Effect of infliximab on sight-threatening panuveitis in Behcet's disease , 2001, The Lancet.

[35]  Justine R. Smith,et al.  Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. , 2001, Arthritis and rheumatism.

[36]  C. Foster,et al.  Low-dose cyclosporine therapy in the treatment of birdshot retinochoroidopathy. , 1994, Ophthalmology.

[37]  W. Green,et al.  Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen. , 1982, American journal of ophthalmology.

[38]  H. Kaplan,et al.  Birdshot retinochoroidopathy. , 1980, American journal of ophthalmology.